Session 5: HIV Prevention Technologies

Session 6: HIV Prevention Technologies
Chaired by: Timothy Mastro and Anita Wadagni
8:30 AM – Combination Prevention and Contraception – State of the Science
Nyaradzo Mavis Mgodi, MBChB, Mmed
University of Zimbabwe Clinical Trials Research Centre, Zimbabwe
8:45 AM – New Prevention Technologies – From Research Findings to Access
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
9:00 AM – Audience Q&A
Oral Abstract Presentations II
Chaired by: Moussa Bachabi and Vanessa Apea
9:15 AM – Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1 Infections
#5 – James Kangethe, Kenya
9:25 AM – Molecular Epidemiology of Human Papillomavirus Circulating in African Countries: Adequacies with Hiv-Infection and Oncogenesis, Systematic Review and Meta-Analysis
#6 – Larissa Gaelle Moko Fotso, Cameroon
9:35 AM – Sexualité Chez Les Adolescents Infectés AU VIH Suivis AU Sein Des Cohortes de Deux Hôpitaux Universitaires AU Sud du Bénin
#7 – Lutécia Zohoun, Bénin
9:45 AM – Comparaison du Profil de Résistance dans l’ARN Viral et l’ADN Proviral chez les Adolescents sous Traitement Antirétroviral avec Virémie Détectable au Cameroun
#8 – Armando Blondel Djiyou Djeuda, Cameroon
9:55 AM – Audience Q&A